홈

Medroxyprogesterone

Medroxyprogesterone

규격

520-85-4CAS 번호
208-298-6EC 번호
(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-oneIUPAC 명칭
C22H32O3화학식
344.5 g/mol분자량
medroxyprogesterone; 520-85-4; Medroxyprogesteron; Medroxiprogesterona; Medroxyprogesteronum; Medrossiprogesterone; 6alpha-Methyl-17alpha-hydroxyprogesterone; 17-Hydroxy-6alpha-methylprogesterone; 17alpha-Hydroxy-6alpha-methylprogesterone; Farlutal inyectable; DTXSID0036508; 6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione; 17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione; HSU1C9YRES; U 8840; (6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione; (6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one; CHEBI:6715; DTXCID8016508; Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)-; G03AC06; NSC27408; 17 alpha Hydroxy 6 alpha Methylprogesterone; 17 alpha-Hydroxy-6 alpha-Methylprogesterone; (6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta(a)phenanthren-3-one; RefChem:55562; (6 alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione; G03DA02; L02AB02; 208-298-6; Methylhydroxyprogesterone; Medroxiprogesteronum; Medroxy Progesterone; MFCD00069474; Medroxyprogesterone (INN); Pregn-4-ene-3,20-dione, 17-hydroxy-6-alpha-methyl-; Medroxyprogesterone (Standard); MLS000069571; MLS001076098; 17-hydroxy-6alpha-methylpregn-4-ene-3,20-dione; SMR000058769; Medrossiprogesterone [DCIT]; NSC 27408; Hydroxymethylprogesterone; Medroxyprogesteronum [INN-Latin]; Medroxiprogesterona [INN-Spanish]; MEDROXYPROGESTERONE [INN]; Medroxyprogesterone [INN:BAN]; 17-Hydroxy-6.alpha.-methylprogesterone; (6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; CAS-520-85-4; 17.alpha.-Hydroxy-6.alpha.-methylprogesterone; 6.alpha.-Methyl-17.alpha.-hydroxyprogesterone; HSDB 3114; 6-alpha-Methyl-17-alpha-hydroxyprogesterone; UNII-HSU1C9YRES; MLS002639162; EINECS 208-298-6; Farlutal inyectable (TN); 17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione; BRN 2510965; Medroxyprogesterone Acetate EP Impurity B; FRQMUZJSZHZSGN-HBNHAYAOSA-N; NCGC00183122-01; 17alpha-Hydroxy-6alpha-methylprogesterone;U8840; CPD000058769; Opera_ID_433; CHEMBL1390; SCHEMBL37494; 4-08-00-02211 (Beilstein Handbook Reference); MLS001424229; GTPL2879; orb1221292; orb1302146; orb3025368; MEDROXYPROGESTERONE [MI]; HY-B0648R; 17-Hydroxy-6a-methylprogesterone; MEDROXYPROGESTERONE [HSDB]; MSK8518; HMS2052A13; HMS2230B08; MEDROXYPROGESTERONE [VANDF]; HY-B0648; Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)-; MEDROXYPROGESTERONE [WHO-DD]; MEDROXYPROGESTERONE [WHO-IP]; Tox21_113401; EBC-04399; LMST02030176; MSK8518-100A; AKOS015961681; MSK8518-1000A; Tox21_113401_1; CCG-101111; FM32162; NC00361; MRF-0000022; 17-Hydroxy-6-methylprogesterone;U8840; NCGC00023064-04; NCGC00023064-05; AC-14528; MS-25295; ST082267; SY076012; CS-0694930; M3113; NS00009207; T5040; C07119; C75441; D08166; Pregn-4-ene-3, 17-hydroxy-6.alpha.-methyl-; F799493; Q416667; Pregn-4-ene-320-dione 17-hydroxy-6-alpha-methyl-; BRD-K99615199-001-18-5; MEDROXYPROGESTERONE ACETATE IMPURITY B [WHO-IP]; Medroxyprogesterone Solution in Acetonitrile, 1000ug/mL; Medroxyprogesterone Solution in Acetonitrile, 100ug/mL; Medroxyprogesterone, VETRANAL(TM), analytical standard; Pregn-4-ene-3, 17-hydroxy-6-methyl-, (6.alpha.)-; Z1501485367; 17-HYDROXY-6.ALPHA.-METHYLPREGN-4-ENE-3,20-DIONE; MEDROXYPROGESTERONE ACETATE IMPURITY B [EP IMPURITY]; (1S,8S,11S,15S,2R,10R,14R)-14-acetyl-14-hydroxy-2,8,15-trimethyl-5-oxotetracyc lo[8.7.0.0<2,7>.0<11,15>]heptadec-6-ene; (6S,8R,10R,13S,17R)-17-Acetyl-17-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one; 17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione; 17-Hydroxy-6alpha-methylprogesterone; 17alpha-Hydroxy-6alpha-methylprogesterone; 6alpha-Methyl-17alpha-hydroxyprogesterone; 6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione; Medroxyprogesteron동의어